Conference abstractPublished 7 Mar 2016
Cell incorporation studies with 99mTc labeled methotrexate loaded chitosan nanoparticles for breast cancer diagnosis
Ege University, Turkey
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The aim of this study is to evaluate newly developed radiopharmaceutical’s (99mTc-MTX-CSNPs) incorporation to human breast cancer (MCF-7) and human keratinocyte (HaCaT) cell lines for breast cancer diagnosis. For this purpose, methotrexate (MTX) loaded chitosan nanoparticles (CSNPs) were prepared by ionic gelation process, storaged during 6 months and evaluated in terms of particle size, polydispersity index value and zeta potential. Produced MTX-CSNPs were radiolabeled by 99mTc with high labeling efficiency (>90%). Then, newly developed radiopharmaceutical’s Target/Non Target ratio was investigated with cell culture studies by using MCF-7 and HaCaT cell lines. Results demonstrated that the incorporation of 99mTc-MTX-CSNPs in breast cancer cells was found about 2-times higher than normal cells. So, 99mTc-MTX-CSNPs might be used for human breast cancer diagnosis in nuclear medicine patients. (The authors thank to Ege University, Scientific Research Projects Comission (Project number: 14/ECZ/037) and Aliye Uster Foundation for financial supports.)
Subjects
NanotechnologyOncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNanotechnology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Meliha Ekinci”